These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 18472486)

  • 1. The effectiveness of anticonvulsants in psychiatric disorders.
    Grunze HC
    Dialogues Clin Neurosci; 2008; 10(1):77-89. PubMed ID: 18472486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsants in bipolar disorder.
    Grunze HC
    J Ment Health; 2010 Apr; 19(2):127-41. PubMed ID: 20433321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticonvulsants treatment of psychiatric disorder in elderly patients].
    Bidzan L
    Przegl Lek; 2006; 63(7):583-7. PubMed ID: 17203814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive review of the psychiatric uses of valproate.
    Davis LL; Ryan W; Adinoff B; Petty F
    J Clin Psychopharmacol; 2000 Feb; 20(1 Suppl 1):1S-17S. PubMed ID: 10646685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
    Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
    Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric and medical comorbidities of bipolar disorder.
    Krishnan KR
    Psychosom Med; 2005; 67(1):1-8. PubMed ID: 15673617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The integration of pharmacological therapy for comorbid psychiatric and addictive disorders.
    Miller NS; Guttman JC
    J Psychoactive Drugs; 1997; 29(3):249-54. PubMed ID: 9339856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and Promises of Pediatric Psychopharmacology.
    Giles LL; Martini DR
    Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.
    Henry C; Van den Bulke D; Bellivier F; Etain B; Rouillon F; Leboyer M
    J Clin Psychiatry; 2003 Mar; 64(3):331-5. PubMed ID: 12716276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.
    Krystal JH; Tolin DF; Sanacora G; Castner SA; Williams GV; Aikins DE; Hoffman RE; D'Souza DC
    Drug Discov Today; 2009 Jul; 14(13-14):690-7. PubMed ID: 19460458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divalproex sodium in substance abusers with mood disorder.
    Albanese MJ; Clodfelter RC; Khantzian EJ
    J Clin Psychiatry; 2000 Dec; 61(12):916-21. PubMed ID: 11206596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of topiramate and other anticonvulsants in the treatment of alcohol dependence: a clinical review.
    De Sousa A
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):45-9. PubMed ID: 20201814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy.
    Johannessen Landmark C
    CNS Drugs; 2008; 22(1):27-47. PubMed ID: 18072813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms.
    Chang KD; Dienes K; Blasey C; Adleman N; Ketter T; Steiner H
    J Clin Psychiatry; 2003 Aug; 64(8):936-42. PubMed ID: 12927009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive side effects of anticonvulsants.
    Goldberg JF; Burdick KE
    J Clin Psychiatry; 2001; 62 Suppl 14():27-33. PubMed ID: 11469672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiepileptic drugs in psychiatry-focus on randomized controlled trial.
    Muzina DJ; El-Sayegh S; Calabrese JR
    Epilepsy Res; 2002 Jun; 50(1-2):195-202. PubMed ID: 12151129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin: a review of published experience in the treatment of bipolar disorder and other psychiatric conditions.
    Letterman L; Markowitz JS
    Pharmacotherapy; 1999 May; 19(5):565-72. PubMed ID: 10331819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder.
    Krystal A; Krishnan KR; Raitiere M; Poland R; Ritchie JC; Dunnick NR; Hanada K; Nemeroff CB
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):34-43. PubMed ID: 1967010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany.
    Post RM; Leverich GS; Altshuler LL; Frye MA; Suppes T; Keck PE; McElroy SL; Nolen WA; Kupka R; Grunze H; Walden J; Rowe M
    Int Clin Psychopharmacol; 2011 Mar; 26(2):96-106. PubMed ID: 21178634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-latency auditory event-related potentials in schizophrenia and in bipolar and unipolar affective disorder.
    Muir WJ; St Clair DM; Blackwood DH
    Psychol Med; 1991 Nov; 21(4):867-79. PubMed ID: 1780401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.